Hemocoagulase is a complex mixture composed of snake venom thrombin-like enzymes (svTLEs) and small amounts of thrombokinase-like enzymes. It has been widely used as a hemostatic with rapidly growing marketing due to its advantage of localized clotting fibrinogen other than systemic coagulation. However, svTLEs from different species have various structures, functions, and hemostatic mechanisms. To ensure the efficacy and safety of Hemocoagulase , an exclusive and sensitive method has been developed to identify specific marker peptides based on liquid chromatography-tandem mass spectrometry with multiple reaction monitoring (LC-MS/MS-MRM) mode. By combining transcriptomics and proteomics, a series of species-specific peptides of were predicted and examined by LC-MS/MS. After reduction, alkylation, and tryptic digestion were performed on Hemocoagulase , a target peptide TLCAGVMEGGIDTCNR was analyzed by LC-MS/MS-MRM. It offers a new and effective approach for the quality control of Hemocoagulase products. This method is superior to the current assays in terms of sensitivity, specificity, precision, accuracy, and throughput. The strategy can also be applied in studying other important protein-based medicines.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196937PMC
http://dx.doi.org/10.3389/fmolb.2022.831293DOI Listing

Publication Analysis

Top Keywords

hemocoagulase
5
species-specific strategy
4
strategy identification
4
identification hemocoagulase
4
hemocoagulase based
4
based lc-ms/ms-mrm
4
lc-ms/ms-mrm hemocoagulase
4
hemocoagulase complex
4
complex mixture
4
mixture composed
4

Similar Publications

Article Synopsis
  • Increased concern among clinicians regarding coagulation disorders linked to hemocoagulase use in gastrointestinal bleeding patients, particularly hypofibrinogenemia, which is not well-understood.
  • Aim of the study was to identify risk factors leading to hypofibrinogenemia associated with hemocoagulase treatment in these patients.
  • Findings revealed that higher hemocoagulase doses, female gender, and lower baseline fibrinogen levels significantly increased the risk of developing hypofibrinogenemia, with implications for patient management in clinical settings.
View Article and Find Full Text PDF

Hematology products from snake venoms.

Thromb Res

January 2025

Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA. Electronic address:

Venoms have primarily been used to prepare antivenoms for the treatment of snake bites, but they have constituents that might serve other medical needs. These include metalloproteinases, serine proteases, phospholipases, and C-type lectin-like proteins. Some of the products that have been prepared from venoms are procoagulants employed as topical hemostatics, and either applied directly to bleeding wounds or used as adjuncts to surgical procedures to assist in controlling blood loss.

View Article and Find Full Text PDF

Stability of Fly Maggot Peptides and Its Alleviating Effect on Lipopolysaccharide Combined with Hemocoagulase Oxidative Stress in Arbor Acres Chicks.

Vet Sci

October 2024

Animal Nutrition, Reproduction and Breeding Laboratory, Department of Animal Science, School of Tropical Agriculture and Forestry, Hainan University, Danzhou 571737, China.

Recently, there has been fast-growing interest among researchers in discovering bioactive peptides from insects and evaluating their potential applications in livestock production. The present study aimed to assess the antioxidant properties and stability of fly maggot peptide (FMP) and its effects on Arbor Acres (AA) broilers' oxidative stress induced by lipopolysaccharide (LPS) and hemocoagulase (HC). A total of 108 one-day-old AA broilers were randomly divided into six groups: CG (normal saline, basal diet), DG (LPS + HC, basal diet), VG (DG + vitamin C 50 ug/kg), LPG (DG + FMP 5 mg/kg), MPG (DG + FMP 15 mg/kg), and HPG (DG + FMP 25 mg/kg).

View Article and Find Full Text PDF

Batroxobin, isolated from Bothrops moojeni, is a defibrinogenating agent used as a thrombin-like serine protease against fibrinogen for improving microcirculation. Here, we investigated whether, and if so, how batroxobin acts in concert with NK cells in terms of anti-tumor effects. CD3+/CD56+ NK cells were isolated and cultured from C57BL/6 mouse spleen.

View Article and Find Full Text PDF

Aims: The objective of this study was to evaluate the effectiveness of batroxobin in improving functional outcomes and reducing stroke recurrence among patients with acute ischemic stroke beyond the therapeutic time window for thrombolytic therapy.

Methods: This multicenter, retrospective study enrolled 492 patients with acute moderate-to-severe ischemic stroke within 24 h. 238 patients were given standard (basic) therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!